fig2
Figure 2. A therapeutic strategy focused on metabolic vulnerabilities and nutrient addiction: glucose metabolism. Effects of erastin on ferroptosis in the absence (A) or presence (B) of GLUT inhibitors. GLUT1/SLC2A1: Glucose transporter 1; PPP: pentose phosphate pathway; xCT: cystine/glutamate antiporter SLC7A11.
